相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Interleukin-8: An evolving chemokine
Kouji Matsushima et al.
CYTOKINE (2022)
The multifaceted role of TRAIL signaling in cancer and immunity
Ludmila Cardoso Alves et al.
FEBS JOURNAL (2021)
Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils
Alvaro Teijeira et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
X-rays induced IL-8 production in lung cancer cells via p38/MAPK and NF-κB pathway
Ying-Hui Song et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2020)
TRAIL Receptors Serve as Stress-Associated Molecular Patterns to Promote ER-Stress-Induced Inflammation
Graeme P. Sullivan et al.
DEVELOPMENTAL CELL (2020)
Activation of epidermal growth factor receptor signaling mediates cellular senescence induced by certain pro-inflammatory cytokines
Dongsheng Shang et al.
AGING CELL (2020)
CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity
Alvaro Teijeira et al.
IMMUNITY (2020)
Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells
Franziska Puschel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Kurt A. Schalper et al.
NATURE MEDICINE (2020)
An unexpected turn of fortune: targeting TRAIL-Rs in KRAS-driven cancer
Silvia von Karstedt et al.
CELL DEATH DISCOVERY (2020)
RIPK3-Induced Inflammation by I-MDSCs Promotes Intestinal Tumors
Asha Jayakumar et al.
CANCER RESEARCH (2019)
Redundant and receptor-specific activities of TRADD, RIPK1 and FADD in death receptor signaling
Simone Fuelsack et al.
CELL DEATH & DISEASE (2019)
Nutrient Deprivation Elicits a Transcriptional and Translational Inflammatory Response Coupled to Decreased Protein Synthesis
Paulo A. Gameiro et al.
CELL REPORTS (2018)
Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors
Raffaella Iurlaro et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
Torsten Hartwig et al.
MOLECULAR CELL (2017)
Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory FADDosome'' Complex upon TRAIL Stimulation
Conor M. Henry et al.
MOLECULAR CELL (2017)
Secretory stressors induce intracellular death receptor accumulation to control apoptosis
Bram J. van Raam et al.
CELL DEATH & DISEASE (2017)
Oncogenic p95HER2/611CTF primes human breast epithelial cells for metabolic stress-induced down-regulation of FLIP and activation of TRAIL-R/Caspase-8-dependent apoptosis
Rosa Martin-Perez et al.
ONCOTARGET (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib
Jeffrey C. Bryan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
Carlos Alfaro et al.
CLINICAL CANCER RESEARCH (2016)
Production of CCL20 from lung cancer cells induces the cell migration and proliferation through PI3K pathway
Beibei Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)
G. R. Blumenschein et al.
ANNALS OF ONCOLOGY (2015)
Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis
Silvia von Karstedt et al.
CANCER CELL (2015)
Phosphorylation of FADD by the kinase CK1α promotes KRASG12D- induced lung cancer
Brittany M. Bowman et al.
SCIENCE SIGNALING (2015)
Fas and TRAIL 'death receptors' as initiators of inflammation: Implications for cancer
Sean P. Cullen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Phosphorylation of FADD by the kinase CK1α promotes KRASG12D- induced lung cancer
Brittany M. Bowman et al.
SCIENCE SIGNALING (2015)
Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma
N. Sunaga et al.
BRITISH JOURNAL OF CANCER (2014)
TAK1 control of cell death
S. R. Mihaly et al.
CELL DEATH AND DIFFERENTIATION (2014)
Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins
Miguel F. Sanmamed et al.
CLINICAL CANCER RESEARCH (2014)
BAY 11-7082, a nuclear factor-κB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells
Ling Chen et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis
Min Lu et al.
SCIENCE (2014)
Inhibition of KRAS-Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit
Zehua Zhu et al.
CANCER DISCOVERY (2014)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
A Quantitative Assay to Study Protein: DNA Interactions, Discover Transcriptional Regulators of Gene Expression, and Identify Novel Anti-tumor Agents
Karen F. Underwood et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2013)
Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer
Noriaki Sunaga et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
ER Stress Activates NF-κB by Integrating Functions of Basal IKK Activity, IRE1 and PERK
Arvin B. Tam et al.
PLOS ONE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Mapping the Transcriptional Machinery of the IL-8 Gene in Human Bronchial Epithelial Cells
Valentino Bezzerri et al.
JOURNAL OF IMMUNOLOGY (2011)
TRAIL-activated stress kinases suppress apoptosis through transcriptional upregulation of MCL-1
J. K. Son et al.
CELL DEATH AND DIFFERENTIATION (2010)
Selective upregulation of interleukin-8 by human rhabdomyosarcomas in response to hypoxia: therapeutic implications
Marcin Wysoczynski et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells
Wei-Lun Huang et al.
MOLECULAR CANCER (2010)
Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines
D. Mahalingam et al.
BRITISH JOURNAL OF CANCER (2009)
TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8
Larisa L. Belyanskaya et al.
LUNG CANCER (2008)
Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation
F. Luppi et al.
LUNG CANCER (2007)
Selective inhibition of IκB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level
Gael Roue et al.
JOURNAL OF IMMUNOLOGY (2007)
Different modulation of TRAIL-induced apoptosis by inhibition of pro-survival pathways in TRAIL-sensitive and TRAIL-resistant colon cancer cells
Alena Vaculova et al.
FEBS LETTERS (2006)
Ultraviolet light activates NFκB through translational inhibition of IκBα synthesis
SY Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2
J Deng et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB
H Ehrhardt et al.
ONCOGENE (2003)
Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer
A Yuan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)